NA
VMD icon

Navellier & Associates’s Viemed Healthcare VMD Stock Holding History

Navellier & Associates’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9,593
Closed -$74K – 321
2020
Q4 		$74K Sell
9,593
-1,119
-10% -$9.85K 0.01% 274
2020
Q3 		$93K Sell
10,712
-1,078
-9% -$10.9K 0.02% 224
2020
Q2 		$113K Buy
+11,790
New +$91.7K 0.03% 227

Other funds holding VMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Navellier & Associates's VMD Position: Q1 2021 in Review

Navellier & Associates sold out of Viemed Healthcare (VMD) in Q1 2021, closing a stake of 9,593 shares — an estimated $74K sold.

Navellier & Associates first reported a position in VMD in Q2 2020 and held it in 3 quarters. The position peaked at $113K in Q2 2020. 100 funds tracked by Wall St. Rank hold VMD as of Q1 2021.

  • Navellier & Associates reported no remaining Viemed Healthcare position as of Q1 2021 after selling out during the quarter.
  • Navellier & Associates sold 9,593 Viemed Healthcare shares in Q1 2021, an estimated $74K.
  • Navellier & Associates first reported a position in Viemed Healthcare in Q2 2020 and held it in 3 quarters.
  • Navellier & Associates's Viemed Healthcare position peaked at $113K in Q2 2020.
  • 100 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2021.

Based on Navellier & Associates's 13F filing for Q1 2021, filed 12 May 2021.